Post-IPO Equity Companies in Cambridge

Vor Biopharma is an immuno-oncology company that develops therapies for treating cancer.

Generation Bio is a biotechnology company that develops genetic medicines to treat genetic disorders.

2seventy bio is an immuno-oncology cell therapy company that discovers and develops cancer therapies.

Bicara Therapeutics develops dual-action cancer therapies, combining targeted treatments with tumor modulators for enhanced impact.

Omega Therapeutics offers a proprietary epigenomic programming platform.

EverQuote is an independent insurance marketplace and is a free service that helps consumers compare quotes on auto insurance.

Foghorn Therapeutics is developing therapies based on a system that directs which genes our cells express,

Praxis develops therapies for CNS disorders by leveraging genetic insights into neuronal imbalances, targeting rare to common conditions.

Voyager Therapeutics is a biotechnology company specializing in gene therapy and neurology.

Third Harmonic Bio is a clinical-stage company developing a first-in-class, highly selective, and oral kit inhibitor.

CAMP4 Therapeutics is a biotechnology company that uses RNA to restore healthy gene expression.

EQRx is a biotechnology company that focuses on re-engineering the process of drug discovery to make them affordable.

Fulcrum Therapeutics is a biotechnology company that focuses on identifying and treating rare genetic diseases at their root cause.

Kymera Therapeutics is a biotechnology company that specializes in the field of targeted protein degradation.

Centessa Pharmaceuticals is a pharmaceutical company that focuses on drug development to address significant medical needs.

Cypherpunk is a biopharmaceutical company developing antibody therapies for cancer while executing a digital-asset treasury strategy.

X4 Pharmaceuticals is a clinical-stage oncology company developing oral small molecule CXCR4 antagonists for the treatment.

C4 Therapeutics develops novel early stage therapies that eliminate disease-causing proteins.

Axcella is a biotechnology company that treats diseases using endogenous metabolic modulators.